Prestige Consumer Healthcare (PBH) Total Liabilities (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Total Liabilities of $1.7 billion for Q4 2025, up 8.06% year-over-year from $1.5 billion in Q4 2024, and up 2.97% quarter-over-quarter from $1.6 billion in Q3 2025.
Prestige Consumer Healthcare (PBH) Total Liabilities (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Total Liabilities history runs 15 years deep, the most recent figure standing at $1.7 billion for Q4 2025.
- In Q4 2025, Total Liabilities rose 8.06% year-over-year to $1.7 billion; the TTM figure through Dec 2025 stood at $1.7 billion (up 8.06% YoY), while the FY2025 annual figure was $1.6 billion, down 5.77% from the prior year.
- Total Liabilities for Q4 2025 stood at $1.7 billion, up from $1.6 billion in the prior quarter.
- The five-year high for Total Liabilities was $2.2 billion in Q3 2021, with the low at $1.5 billion in Q4 2024.
- The 5-year median for Total Liabilities is $1.8 billion (2023), against an average of $1.9 billion.
- The sharpest annual moves came in 2023 and 2025: Total Liabilities retreated 15.69% in 2023, then advanced 8.06% in 2025.
- Prestige Consumer Healthcare's Total Liabilities stood at $2.1 billion in 2021, then retreated by 3.65% to $2.1 billion in 2022, then slipped by 15.69% to $1.7 billion in 2023, then retreated by 11.39% to $1.5 billion in 2024, then rose by 8.06% to $1.7 billion in 2025.
- Business Quant data shows PBH's Total Liabilities at $1.7 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.6 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.12 Bn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | - | 1.61 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.61 Bn |
| Dec 31, 2025 | 1.67 Bn |
| Sep 30, 2025 | 1.62 Bn |
| Jun 30, 2025 | 1.58 Bn |
| Mar 31, 2025 | 1.57 Bn |
| Dec 31, 2024 | 1.54 Bn |
| Sep 30, 2024 | 1.59 Bn |
| Jun 30, 2024 | 1.63 Bn |
| Mar 31, 2024 | 1.66 Bn |
| Dec 31, 2023 | 1.74 Bn |
| Sep 30, 2023 | 1.80 Bn |
| Jun 30, 2023 | 1.87 Bn |
| Mar 31, 2023 | 1.91 Bn |
| Dec 31, 2022 | 2.06 Bn |
| Sep 30, 2022 | 2.06 Bn |
| Jun 30, 2022 | 2.10 Bn |
| Mar 31, 2022 | 2.09 Bn |
| Dec 31, 2021 | 2.14 Bn |
| Sep 30, 2021 | 2.21 Bn |
| Jun 30, 2021 | 2.14 Bn |